CLASS III Device recall · Reported 24 Aug 2016 · FDA Enforcement Report

Vitros Immunodiagnostic Products TSH Reagent Pack recalled

Ortho-clinical Diagnostics is recalling Vitros Immunodiagnostic Products TSH Reagent Pack, distributed in 9 states. The recall was initiated on 28 Jul 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 5040 (Expiry date 19 Dec 2016)
Quantity recalledDomestic: 2883, Foreign: 1261

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2580-2016
FDA event ID
74828
Recalling firm
Ortho-clinical Diagnostics, Bridgend, N/A
Classification
Class III
Status
Terminated
Recall initiated
28 Jul 2016
FDA classified
17 Aug 2016
Reported
24 Aug 2016
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

28 Jul 2016Recall initiated by company
17 Aug 2016Classified by FDA+20 days
24 Aug 2016Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A field correction was issued by the firm for VITROS TSH reagent lot 5040 due to a higher than expected frequency of customer calibration curves falling outside of the calibration quality parameters and therefore unusable to process samples. Customers using VITROS TSH Lot 5040 will potentially experience an unexpected increase in the unsuccessful calibrations potentially causing a delay in testing and reporting results for VITROS TSH.

Product as listed by the FDA

VITROS Immunodiagnostic Products TSH Reagent Pack, REF/Catalog Number/Product Code 191 2997, Unique Device Identifier No. 10758750000227, IVD --- Ortho-Clinical Diagnostics Pencoed Bridgend CF35 5PZ UK For the in vitro quantitative measurement of thyroid stimulating hormone (TSH) in human serum and plasma (EDTA or heparin) using the VITROS ECi/ECiQ Immunodiagnostic Systems, the VITROS 3600 Immunodiagnostic System and the VITROS 5600 Integrated System to aid in the differential diagnosis of thyroid disease.

Where it was distributed

Worldwide Distribution - US to VA, WV, GA, TN, KY, MN, SD, AR, OK and Internationally to Canada

ArkansasGeorgiaKentuckyMinnesotaOklahomaSouth DakotaTennesseeVirginiaWest Virginia

Questions about this recall

Why was it recalled?

A field correction was issued by the firm for VITROS TSH reagent lot 5040 due to a higher than expected frequency of customer calibration curves falling outside of the calibration quality parameters and therefore unusable to process samples. Customers using VITROS TSH Lot 5040 will potentially experience an unexpected increase in the unsuccessful calibrations potentially causing a delay in testing and reporting results for VITROS TSH.

Which lots are affected?

Lot 5040 (Expiry date 19 Dec 2016)

Where was it sold?

Worldwide Distribution - US to VA, WV, GA, TN, KY, MN, SD, AR, OK and Internationally to Canada

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ortho-clinical Diagnostics

All 311

Other Test Kits & Diagnostics recalls

All 2,656